Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Epidemiology of Alpha-1 Antitrypsin Deficiency in the Veterans Health Administration.

Annals of the American Thoracic Society - 1 Feb 2026

Riley Leonard, Fredenrich Robert, Bearce Matthew, Govindan Sushant, Schafer Spencer, Campos Michael, Lascano Jorge

Abstract excerpt

RATIONALE: AAT (alpha-1 antitrypsin) deficiency (AATD) is a known but underrecognized genetic cause of chronic obstructive pulmonary disease (COPD) and liver disease. Little is known about the epidemiology and burden of AATD among U.S. veterans. OBJECTIVES: To examine the veteran characteristics and epidemiology of AATD and severe AATD throughout the Veterans Health Administration. METHODS: Data were obtained...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to alpha 1-Antitrypsin Deficiency

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genotype

Share to Logistic Models

Share to Pulmonary Disease, Chronic Obstructive

Share to United States

Share to Veterans

Source

Identifiers

PMID: 40772933
DOI: 10.1513/AnnalsATS.202503-325OC

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Epidemiology of Alpha-1 Antitrypsin Deficiency in the Veterans Health Administration.PMID 40772933Read ↗

Alpha-1 Antitrypsin Deficiency in Patients With Cirrhosis in a US National Cohort.Semantic proximity Read ↗

Testing Patterns and Disparities for Alpha-1 Antitrypsin Deficiency.Semantic proximity Read ↗

Recent advances in understanding and treating COPD related to α1-antitrypsin deficiency.Semantic proximity Read ↗

The need for continuous quality assessment for providing optimal comprehensive care for patients with alpha-1 antitrypsin deficiency.Semantic proximity Read ↗

Recommendations for the diagnosis and treatment of alpha-1 antitrypsin deficiency.Semantic proximity Read ↗

Advances in managing COPD related to α1 -antitrypsin deficiency: An under-recognized genetic disorder.Semantic proximity Read ↗

Update on and future perspectives for the diagnosis of alpha-1 antitrypsin deficiency in Brazil.Semantic proximity Read ↗

Alpha1-antitrypsin deficiency: incidence and detection program.Semantic proximity Read ↗

The important role of primary care providers in the detection of alpha-1 antitrypsin deficiency.Semantic proximity Read ↗

Alpha-1 Antitrypsin Deficiency: Current Landscape of Detection, Management, and Treatment.Semantic proximity Read ↗

Alpha-1 antitrypsin deficiency-associated liver disease: From understudied disorder to the poster child of genetic medicineSemantic proximity Read ↗

Alpha-1-antitrypsin deficiency.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.